Studies on the structure and regulation of the human hepatic interleukin-6 receptor

Eur J Biochem. 1990 May 31;190(1):79-83. doi: 10.1111/j.1432-1033.1990.tb15548.x.

Abstract

Affinity cross-linking of 125I-labeled recombinant human interleukin-6 (IL-6) to human hepatoma cells (HepG2) allowed the detection of three IL-6-containing complexes with molecular masses of 100 kDa, 120 kDa and 200 kDa. Treatment of HepG2 cells with dexamethasone led to a time- and dose-dependent up-regulation of IL-6-receptor mRNA levels. By the use of cross-linking this effect was also seen at the protein level, where all three IL-6-binding complexes increased upon incubation of HepG2 cells with dexamethasone. Under conditions of IL-6-receptor up-regulation by dexamethasone, gamma-fibrinogen mRNA induction by IL-6 is stronger and occurs earlier than without dexamethasone. We propose therefore that the expression of the IL-6 receptor might be a rate-limiting step in acute-phase-protein induction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Hepatocellular / metabolism
  • Dexamethasone / pharmacology*
  • Fibrinogen / genetics
  • Fibrinogen / metabolism
  • Gene Expression Regulation, Neoplastic*
  • Genes, Neoplasm*
  • Humans
  • Interleukin-6 / pharmacology
  • Liver Neoplasms / metabolism
  • RNA, Messenger / metabolism*
  • Receptors, Immunologic / drug effects*
  • Receptors, Immunologic / genetics
  • Receptors, Interleukin-6
  • Recombinant Proteins / pharmacology
  • Tumor Cells, Cultured / drug effects
  • Up-Regulation / drug effects

Substances

  • Interleukin-6
  • RNA, Messenger
  • Receptors, Immunologic
  • Receptors, Interleukin-6
  • Recombinant Proteins
  • Dexamethasone
  • Fibrinogen